Carl Zeiss Meditec AG

AFX

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,784

Stocks News & Analysis

stocks

Lower fair value on ASX best idea

Shares are still undervalued despite drop in profit margins.
stocks

We raise our near-term gold price assumptions

Our coverage remains overvalued.
stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,184.2027.30-0.30%
CAC 408,310.9919.97-0.24%
DAX 4025,267.2618.98-0.08%
Dow JONES (US)49,149.6342.36-0.09%
FTSE 10010,188.894.540.04%
HKSE26,923.6276.19-0.28%
NASDAQ23,471.75238.13-1.00%
Nikkei 22554,110.50230.73-0.42%
NZX 50 Index13,659.7997.92-0.71%
S&P 5006,926.6037.14-0.53%
S&P/ASX 2008,861.7019.30-0.22%
SSE Composite Index4,112.6013.49-0.33%

Market Movers